• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

    14.79 -0.77 (-4.95%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Adaptive Biotechnologies Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
    The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
    Via Benzinga
    Topics ETFs Stocks
    Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Jabil Posts Upbeat Earnings, Joins Micron Technology, Southwest Airlines And Other Big Stocks Moving Higher On Thursday
     
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
     
    Via Benzinga
    Crude Oil Down Over 2%; US Initial Jobless Claims Fall
     
    Via Benzinga
    A Biotech Breakout Will Be Led By Small Caps
    It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
    Via Talk Markets
    Topics Artificial Intelligence Economy
    Adaptive Announces IVDR Certification for clonoSEQ® in European Union
    clonoSEQ is the first IVDR-certified test to detect minimal residual disease in patients with lymphoid malignancies 
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    3 Precision Medicine Stocks Tailoring Treatments
    With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider. 
    Via InvestorPlace
    Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
     
    Via Benzinga
    Topics Artificial Intelligence
    Trading SMID Biotech Stocks In A Volatile Market
    Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... 
    Via Talk Markets
    Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
    More than 20 abstracts will be presented from clinical trials and real-world evidence using clonoSEQ for MRD assessment across multiple types of blood cancers 
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch
    While small-cap stocks to buy present a higher-risk profile, these ideas may also pack considerable punch for their size. 
    Via InvestorPlace
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    The popular growth investor keeps adding to some of her favorite falling stocks. 
    Via The Motley Fool
    Why Adaptive Biotechnologies Topped the Market Today
    A double beat on earnings, plus positive adjustments to certain guidance items, lifted the company's shares. 
    Via The Motley Fool
    ADPT Stock Earnings: Adaptive Biotechnologies Beats EPS, Beats Revenue for Q1 2024
    ADPT stock results show that Adaptive Biotechnologies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
     
    Via Benzinga
    Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position
    Adaptive Biotechnologies announces strategic restructuring to enhance independence and financial strength. 
    Via Benzinga
    Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
    Announces CFO transition 
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. 
    Via Benzinga
    The 7 Best Penny Stocks to Buy in Q2 2024
    Discover seven penny stocks to buy primed for significant gains in Q2 2024. Don't miss out on these picks or your portfolio could suffer. 
    Via InvestorPlace
    Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.